IL17A and inflammatory bowel disease: IL-17 and IL-23 are cytokines implicated in autoimmune and inflammatory bowel diseases and the maintenance of colon homeostasis [54–56], which promotes CRC development, progression, and metastasis and reduces the efficacy of immune therapy [55, 57–59].